New Haven, CT, United States of America

Ivan C King



Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 117(Granted Patents)


Location History:

  • New Haven, CT (US) (2005 - 2008)
  • North Haven, CT (US) (2005 - 2011)

Company Filing History:


Years Active: 2005-2011

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Ivan C King: Innovator in Anti-Neoplasia Agents

Introduction

Ivan C King is a notable inventor based in New Haven, CT, with a significant contribution to the field of anti-neoplasia agents. He holds a total of 8 patents, showcasing his dedication to advancing cancer treatment methodologies. His work focuses on developing effective and innovative solutions for combating cancer.

Latest Patents

One of King’s latest patents is titled "Process for the synthesis of anti-neoplasia agent VNP40101M." This invention relates to simple, safe, and high-yield methods of synthesizing VNP40101M, which is identified as 1,2-bis(methylsulfonyl)-2-(2-chloroethyl)-2-(methylaminocarbonyl)hydrazine. A particularly preferred method involves using methyl chloroformamide in a one-pot reaction at elevated temperatures to achieve high yields of VNP40101M. Another significant patent is "Combination therapy comprising cloretazine," which provides a method for treating tumors in subjects by administering an effective amount of VNP40101M or its equivalent, along with a nucleoside or a nucleoside analog. This invention also outlines a method for inhibiting tumor cell growth by contacting tumor cells with effective amounts of VNP40101M and a nucleoside.

Career Highlights

Throughout his career, Ivan C King has worked with prominent organizations such as Vion Pharmaceuticals, Inc. and Yale University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in cancer treatment.

Collaborations

Some of King’s notable coworkers include Michael Belcourt and Xu Kevin Lin. Their collaborative efforts have further enhanced the research and development of innovative cancer therapies.

Conclusion

Ivan C King stands out as a significant figure in the field of anti-neoplasia research, with a strong portfolio of patents that reflect his commitment to improving cancer treatment. His innovative approaches and collaborations continue to influence the landscape of cancer therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…